TrialMolecular therapy : the journal of the American Society of Gene Therapy2022

A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models.

Giulietta Maruggi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.